8/11/2014 11:05:43 AM
WOBURN, MASSACHUSETTS, August 11, 2014—Bioprocess Technology Consultants, Inc. (BPTC), the leading strategic, technical, and regulatory consulting company for the global biopharmaceutical industry, has promoted Susan Dana Jones, Ph.D., and Thomas C. Ransohoff to Principal Consultants. As Vice Presidents and Principal Consultants, they will continue to head client programs as well as assume greater management roles within the Company.
A seasoned biotechnology entrepreneur, Dr. Jones joined BPTC in 2002. She is the co-founder of three successful biotechnology companies and known for her expertise in cell line development, cell culture, and process development for biopharmaceutical and vaccine products. She has managed multiple discovery and product development programs, and advises clients on manufacturing and regulatory issues. She is a member of the Board of Directors of Gene Solutions, LLC, the Symphogen A/S Scientific Advisory Board, and the Editorial Advisory Board of BioProcess International. Prior to joining BPTC, she was Senior Vice President of Corporate Development at Serenex, Inc. She received her B.S. in Biochemistry from Harvard University, holds a Ph.D. in Genetics from the University of California, San Francisco, and performed post-doctoral research at the Dana-Farber Cancer Institute of Harvard Medical School.
Mr. Ransohoff, who joined BPTC in 2002, has over 25 years of experience in the biopharmaceutical industry with expertise in the development and scale-up of biopharmaceutical processes; separations and purification technologies; process economic modeling; cGMP manufacturing; and management of technology-based start-up ventures. He guides clients through all stages of product development, advising on CMC strategy including regulatory, commercial, and manufacturing decisions. He is the co founder of two successful biotechnology companies, and previously held senior level positions at TranXenoGen, Dyax, and Repligen. Mr. Ransohoff is a member of the Editorial Advisory Board of BioPharm Magazine, and has served on a number of scientific and professional advisory boards. He has a B.S. from MIT and an M.S. from the University of California, Berkeley, both in Chemical Engineering.
“Both Tom and Susan have been long-time contributors to building and managing BPTC, and have been instrumental in helping the Company achieve a leadership position in the industry,” said Howard Levine, BPTC President and Founder. “They are both widely recognized as subject matter experts in a variety of areas, and many clients have expressed how valuable they have been to advancing their companies' product development programs. I look forward to their continuing efforts to lead client programs and assist with the management of our growing business.”
About BioProcess Technology Consultants
Founded in 1994, BPTC is the recognized worldwide leader in biologics Chemistry, Manufacturing, and Controls (CMC) consulting, providing a full range of technical, regulatory, and strategic assistance to pharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The Company works with clients globally to find and apply solutions to the challenges of biopharmaceutical product development from clone to commercial®. BPTC helps develop manufacturing processes and strategies that enhance the overall value of client companies and accelerate the advancement of new products from clone to clinic®. BPTC also helps investors make informed decisions by providing technical and business evaluations of new products and technologies and product discovery, development, and commercialization plans of potential investments and existing portfolio companies. For more information about BPTC, visit http://www.bptc.com and follow the Company on Twitter at bptcGlobal or LinkedIn at http://www.linkedin.com/company/bioprocess-technology-consultants-inc.
Help employers find you! Check out all the jobs and post your resume.
comments powered by